CWBHF Charlotte's Web Holdings, Inc.
Price Chart
Executive Summary
Charlotte's Web closed its previously announced transaction with BAT, converting C$75.3M of convertible debentures plus accrued interest into 95.3M shares and raising an additional US$10M via a private placement. BAT now holds ~40.6% of the pro-forma shares outstanding. Shareholders also approved the transaction and elected directors, including a new BAT-appointed board member. The deal eliminates debt overhang and provides fresh cash, but at the cost of massive dilution to existing shareholders.
Actionable Insight
The transaction removes a large debt overhang and provides a US$10M cash infusion, but at the cost of ~41% dilution to existing holders. BAT now holds a controlling stake, which could lead to further strategic alignment or a potential take-private. Monitor for TSX final approval and any subsequent capital allocation moves by the new controlling shareholder.
Key Facts
- BAT's C$75.3M convertible debenture (plus C$14.2M accrued interest) converted into 95,281,277 common shares at C$0.94/share.
- BAT concurrently invested an additional US$10M via a private placement of 14,662,765 shares at C$0.94/share.
- Total of 109,944,042 new shares issued to BAT, representing 40.6% of the combined 270,549,931 shares outstanding post-closing.
- Shareholders approved the transaction with 94% of votes cast in favor.
- James Jeffery Raborn (EVP & GC of Reynolds American/BAT) appointed to the board as a BAT designee.
- Net proceeds from the US$10M private placement will support participation in the CMMI Medicare pilot program and other medical channel initiatives.
Financial Impact
C$89.6M (US$65M) of debt and accrued interest eliminated; US$10M new equity raised; existing shareholders diluted from ~160.6M shares to ~270.5M shares (40.6% to BAT).
Risk Factors
- Massive dilution (~41%) to existing non-BAT shareholders.
- BAT now holds a controlling interest, potentially limiting minority shareholder influence.
- The CMMI Medicare pilot program is subject to regulatory approvals and may not materialize as expected.
- Historical performance on this ticker shows poor follow-through on positive catalysts.
Market Snapshot
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001750155-26-000080 |
| Document: cwebmay28-2026agmresults.htm | 0001750155-26-000080 |
| Document: cweb-may28_2026batdebentur.htm | 0001750155-26-000080 |
| Document: 0001750155-26-000080-index-headers.html | 0001750155-26-000080 |
| Document: 0001750155-26-000080-index.html | 0001750155-26-000080 |
| Document: 0001750155-26-000080.txt | 0001750155-26-000080 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 5, 2026
7d ago
|
8-K
| $0.4390 awaiting T+1 | awaiting T+1 | — | $0.3980 (−9.34%) |
|
Jun 3, 2026
9d ago
|
8-K
| $0.4170 $0.4320 | ▲ +3.60% | ▲ +6.20% | $0.3980 (−4.56%) |
|
Jun 1, 2026
11d ago
|
8-K
| $0.4910 $0.4260 | ▼ −13.24% | ▼ −12.52% | $0.3980 (−18.94%) |
|
May 13, 2026
4w ago
|
8-K
| $0.4860 $0.4520 | ▲ +7.00% | ▲ +7.77% | $0.3980 (+18.11%) |
|
Apr 16, 2026
8w ago
|
DEFA14A
| $0.6080 $0.6150 | ▲ +1.15% | ▼ −0.06% | $0.3980 (−34.54%) |
|
Mar 31, 2026
10w ago
|
8-K
| $0.7350 $0.7820 | ▲ +6.39% | ▲ +5.65% | $0.3980 (−45.85%) |
|
Mar 31, 2026
10w ago
|
DEFA14A
| $0.7350 $0.7820 | ▲ +6.39% | ▲ +5.65% | $0.3980 (−45.85%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access